ID   PPA6_HUMAN              Reviewed;         428 AA.
AC   Q9NPH0; Q59G61; Q5T490; Q6IAQ3; Q7LG81; Q9UIG6;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   12-APR-2017, entry version 135.
DE   RecName: Full=Lysophosphatidic acid phosphatase type 6;
DE            EC=3.1.3.2;
DE   AltName: Full=Acid phosphatase 6, lysophosphatidic;
DE   AltName: Full=Acid phosphatase-like protein 1;
DE   AltName: Full=PACPL1;
DE   Flags: Precursor;
GN   Name=ACP6; Synonyms=ACPL1, LPAP; ORFNames=UNQ205/PRO231;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF HIS-59, INDUCTION, AND VARIANT
RP   MET-316.
RC   TISSUE=Brain;
RX   PubMed=10506173; DOI=10.1074/jbc.274.41.29172;
RA   Hiroyama M., Takenawa T.;
RT   "Isolation of a cDNA encoding human lysophosphatidic acid phosphatase
RT   that is involved in the regulation of mitochondrial lipid
RT   biosynthesis.";
RL   J. Biol. Chem. 274:29172-29180(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT MET-316.
RX   PubMed=12010880; DOI=10.1136/gut.50.6.790;
RA   Takayama I., Daigo Y., Ward S.M., Sanders K.M., Walker R.L.,
RA   Horowitz B., Yamanaka T., Fujino M.A.;
RT   "Novel human and mouse genes encoding an acid phosphatase family
RT   member and its downregulation in W/W(V) mouse jejunum.";
RL   Gut 50:790-796(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-316.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-316.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-316.
RC   TISSUE=Cervix, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-428 (ISOFORM 1), AND
RP   VARIANT MET-316.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PROTEIN SEQUENCE OF 33-47.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.17 ANGSTROMS) OF 33-428 IN COMPLEXES WITH
RP   MALONATE AND TARTRATE, ACTIVE SITE, PROBABLE SUBSTRATE-BINDING SITES,
RP   CATALYTIC ACTIVITY, FUNCTION, SUBUNIT, AND MUTAGENESIS OF ARG-58;
RP   HIS-59; ARG-62; TYR-106; ARG-168; ALA-257; SER-285; LEU-289; HIS-334
RP   AND ASP-335.
RX   PubMed=23807634; DOI=10.1007/s13238-013-3031-z;
RA   Li J., Dong Y., Lu X., Wang L., Peng W., Zhang X.C., Rao Z.;
RT   "Crystal structures and biochemical studies of human lysophosphatidic
RT   acid phosphatase type 6.";
RL   Protein Cell 4:548-561(2013).
CC   -!- FUNCTION: Hydrolyzes lysophosphatidic acid (LPA) containing a
CC       medium length fatty acid chain to the corresponding
CC       monoacylglycerol. Has highest activity with lysophosphatidic acid
CC       containing myristate (C14:0), monounsaturated oleate (C18:1) or
CC       palmitate (C16:0), and lower activity with C18:0 and C6:0
CC       lysophosphatidic acid. {ECO:0000269|PubMed:10506173,
CC       ECO:0000269|PubMed:23807634}.
CC   -!- CATALYTIC ACTIVITY: A phosphate monoester + H(2)O = an alcohol +
CC       phosphate. {ECO:0000269|PubMed:23807634}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:23807634}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:10506173}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NPH0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NPH0-2; Sequence=VSP_014121, VSP_014122;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, heart, small
CC       intestine, muscle, liver, prostate, testis, ovary and weakly
CC       expressed in thymus and colon. {ECO:0000269|PubMed:10506173,
CC       ECO:0000269|PubMed:12010880}.
CC   -!- INDUCTION: Induced with the differentiation from myoblast to
CC       myotube. {ECO:0000269|PubMed:10506173}.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-8 is the initiator.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally reported to be located in the
CC       mitochondrion, but the evidence seems to be weak and contradictory
CC       with the presence of a cleaved signal sequence.
CC       {ECO:0000305|PubMed:10506173}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA89311.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAD92485.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB031478; BAA89311.1; ALT_INIT; mRNA.
DR   EMBL; AB030039; BAA94309.2; -; mRNA.
DR   EMBL; AY358552; AAQ88916.1; -; mRNA.
DR   EMBL; AK000657; BAA91310.1; -; mRNA.
DR   EMBL; AB209248; BAD92485.1; ALT_INIT; mRNA.
DR   EMBL; AL359207; CAI15199.1; -; Genomic_DNA.
DR   EMBL; BC009965; AAH09965.1; -; mRNA.
DR   EMBL; BC034686; AAH34686.1; -; mRNA.
DR   EMBL; CR457101; CAG33382.1; -; mRNA.
DR   CCDS; CCDS928.1; -. [Q9NPH0-1]
DR   RefSeq; NP_057445.4; NM_016361.4.
DR   UniGene; Hs.562154; -.
DR   PDB; 4JOB; X-ray; 2.17 A; A=33-428.
DR   PDB; 4JOC; X-ray; 2.21 A; A=33-428.
DR   PDB; 4JOD; X-ray; 2.21 A; A=33-428.
DR   PDBsum; 4JOB; -.
DR   PDBsum; 4JOC; -.
DR   PDBsum; 4JOD; -.
DR   ProteinModelPortal; Q9NPH0; -.
DR   SMR; Q9NPH0; -.
DR   BioGrid; 119378; 21.
DR   IntAct; Q9NPH0; 2.
DR   MINT; MINT-1387194; -.
DR   STRING; 9606.ENSP00000358241; -.
DR   SwissLipids; SLP:000001294; -.
DR   DEPOD; Q9NPH0; -.
DR   iPTMnet; Q9NPH0; -.
DR   PhosphoSitePlus; Q9NPH0; -.
DR   DMDM; 317373268; -.
DR   EPD; Q9NPH0; -.
DR   MaxQB; Q9NPH0; -.
DR   PaxDb; Q9NPH0; -.
DR   PeptideAtlas; Q9NPH0; -.
DR   PRIDE; Q9NPH0; -.
DR   DNASU; 51205; -.
DR   Ensembl; ENST00000487562; ENSP00000481777; ENSG00000162836. [Q9NPH0-2]
DR   GeneID; 51205; -.
DR   KEGG; hsa:51205; -.
DR   CTD; 51205; -.
DR   DisGeNET; 51205; -.
DR   GeneCards; ACP6; -.
DR   H-InvDB; HIX0000989; -.
DR   HGNC; HGNC:29609; ACP6.
DR   HPA; HPA028560; -.
DR   MIM; 611471; gene.
DR   neXtProt; NX_Q9NPH0; -.
DR   OpenTargets; ENSG00000162836; -.
DR   PharmGKB; PA134930830; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   GeneTree; ENSGT00530000062956; -.
DR   HOGENOM; HOG000290692; -.
DR   HOVERGEN; HBG079458; -.
DR   InParanoid; Q9NPH0; -.
DR   KO; K14395; -.
DR   PhylomeDB; Q9NPH0; -.
DR   TreeFam; TF318821; -.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   ChiTaRS; ACP6; human.
DR   GeneWiki; ACP6; -.
DR   GenomeRNAi; 51205; -.
DR   PRO; PR:Q9NPH0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162836; -.
DR   CleanEx; HS_ACP6; -.
DR   ExpressionAtlas; Q9NPH0; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0003993; F:acid phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052642; F:lysophosphatidic acid phosphatase activity; IDA:UniProtKB.
DR   GO; GO:2001311; P:lysobisphosphatidic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; IMP:UniProtKB.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 2.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Hydrolase; Lipid metabolism; Mitochondrion;
KW   Phospholipid metabolism; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     32       Mitochondrion.
FT                                {ECO:0000269|PubMed:15340161}.
FT   CHAIN        33    428       Lysophosphatidic acid phosphatase type 6.
FT                                /FTId=PRO_0000023965.
FT   REGION       58    168       Substrate binding. {ECO:0000250}.
FT   ACT_SITE     59     59       Nucleophile.
FT                                {ECO:0000269|PubMed:23807634}.
FT   ACT_SITE    335    335       Proton donor.
FT                                {ECO:0000305|PubMed:23807634}.
FT   VAR_SEQ     261    271       AHNLPSCPMLK -> EKMGSCRFHGS (in isoform
FT                                2). {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_014121.
FT   VAR_SEQ     272    428       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_014122.
FT   VARIANT     316    316       V -> M (in dbSNP:rs6593795).
FT                                {ECO:0000269|PubMed:10506173,
FT                                ECO:0000269|PubMed:12010880,
FT                                ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_022678.
FT   MUTAGEN      58     58       R->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN      59     59       H->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10506173,
FT                                ECO:0000269|PubMed:23807634}.
FT   MUTAGEN      62     62       R->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     106    106       Y->F: Decreases enzyme activity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     110    110       Y->F: Decreases enzyme activity.
FT   MUTAGEN     168    168       R->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     257    257       A->F,L: Decreases enzyme activity by
FT                                interfering with water access to the
FT                                active site cavity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     257    257       A->W: Abolishes enzyme activity by
FT                                interfering with water access to the
FT                                active site cavity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     285    285       S->W: Decreases activity toward
FT                                substrates with medium and long aliphatic
FT                                chains, but not toward substrates with
FT                                short aliphatic chains.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     289    289       L->W: Decreases activity toward
FT                                substrates with medium and long aliphatic
FT                                chains, but not toward substrates with
FT                                short aliphatic chains.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     334    334       H->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   MUTAGEN     335    335       D->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:23807634}.
FT   CONFLICT    428    428       E -> D (in Ref. 8; CAG33382).
FT                                {ECO:0000305}.
FT   HELIX        45     47       {ECO:0000244|PDB:4JOB}.
FT   STRAND       48     58       {ECO:0000244|PDB:4JOB}.
FT   STRAND       69     71       {ECO:0000244|PDB:4JOB}.
FT   HELIX        78     81       {ECO:0000244|PDB:4JOB}.
FT   HELIX        85     87       {ECO:0000244|PDB:4JOB}.
FT   STRAND       92    100       {ECO:0000244|PDB:4JOB}.
FT   HELIX       105    111       {ECO:0000244|PDB:4JOD}.
FT   TURN        116    118       {ECO:0000244|PDB:4JOC}.
FT   HELIX       126    143       {ECO:0000244|PDB:4JOB}.
FT   TURN        144    146       {ECO:0000244|PDB:4JOC}.
FT   STRAND      152    154       {ECO:0000244|PDB:4JOB}.
FT   TURN        156    158       {ECO:0000244|PDB:4JOB}.
FT   STRAND      159    163       {ECO:0000244|PDB:4JOB}.
FT   HELIX       167    181       {ECO:0000244|PDB:4JOB}.
FT   STRAND      185    187       {ECO:0000244|PDB:4JOB}.
FT   STRAND      190    193       {ECO:0000244|PDB:4JOB}.
FT   TURN        196    198       {ECO:0000244|PDB:4JOB}.
FT   TURN        205    207       {ECO:0000244|PDB:4JOB}.
FT   HELIX       209    221       {ECO:0000244|PDB:4JOB}.
FT   HELIX       222    224       {ECO:0000244|PDB:4JOB}.
FT   HELIX       228    238       {ECO:0000244|PDB:4JOB}.
FT   HELIX       249    261       {ECO:0000244|PDB:4JOB}.
FT   HELIX       268    272       {ECO:0000244|PDB:4JOB}.
FT   HELIX       274    288       {ECO:0000244|PDB:4JOB}.
FT   HELIX       294    314       {ECO:0000244|PDB:4JOB}.
FT   STRAND      318    320       {ECO:0000244|PDB:4JOD}.
FT   TURN        322    324       {ECO:0000244|PDB:4JOD}.
FT   STRAND      327    333       {ECO:0000244|PDB:4JOB}.
FT   HELIX       335    344       {ECO:0000244|PDB:4JOB}.
FT   STRAND      358    366       {ECO:0000244|PDB:4JOB}.
FT   TURN        367    369       {ECO:0000244|PDB:4JOB}.
FT   STRAND      372    378       {ECO:0000244|PDB:4JOB}.
FT   STRAND      381    383       {ECO:0000244|PDB:4JOC}.
FT   STRAND      389    394       {ECO:0000244|PDB:4JOB}.
FT   HELIX       395    402       {ECO:0000244|PDB:4JOB}.
FT   TURN        403    405       {ECO:0000244|PDB:4JOB}.
FT   HELIX       409    416       {ECO:0000244|PDB:4JOB}.
SQ   SEQUENCE   428 AA;  48854 MW;  37A09CFD1BB45BFA CRC64;
     MITGVFSMRL WTPVGVLTSL AYCLHQRRVA LAELQEADGQ CPVDRSLLKL KMVQVVFRHG
     ARSPLKPLPL EEQVEWNPQL LEVPPQTQFD YTVTNLAGGP KPYSPYDSQY HETTLKGGMF
     AGQLTKVGMQ QMFALGERLR KNYVEDIPFL SPTFNPQEVF IRSTNIFRNL ESTRCLLAGL
     FQCQKEGPII IHTDEADSEV LYPNYQSCWS LRQRTRGRRQ TASLQPGISE DLKKVKDRMG
     IDSSDKVDFF ILLDNVAAEQ AHNLPSCPML KRFARMIEQR AVDTSLYILP KEDRESLQMA
     VGPFLHILES NLLKAVDSAT APDKIRKLYL YAAHDVTFIP LLMTLGIFDH KWPPFAVDLT
     MELYQHLESK EWFVQLYYHG KEQVPRGCPD GLCPLDMFLN AMSVYTLSPE KYHALCSQTQ
     VMEVGNEE
//
